Glucotrack Resolves $10.9M Alto Dispute with $4.1M in Payments and Convertible Note
GCTK is trading near its 52-week low of $2.9 (9.3% above the low) on light trading volume (0.1× avg).
Summary
Glucotrack settled a $10.9 million disputed debt claim with Alto Opportunity Master Fund for $2.0 million cash, a $2.0 million convertible note, and up to $125,000 in legal fees. The note converts at $2.98 per share, below the current price.
Key Events · Legal and Risk Events · GCTK
-
Settlement Resolves $10.9M Disputed Debt
A Settlement and Release Agreement with Alto Opportunity Master Fund resolves a disputed ~$10.9 million indebtedness claim related to Apimeds Pharmaceuticals US, Inc.
-
Total Settlement Obligation $4.125M
The company must pay $2.0 million upfront, issue a $2.0 million convertible note, and reimburse up to $125,000 in Alto's legal fees — joint and several with other settling parties.
-
Convertible Note Terms
The note bears 5% interest, payable in four $500,000 quarterly installments starting November 30, 2026 through August 31, 2027. It is convertible at $2.98 per share with a 9.99% beneficial ownership cap.
-
Cash Crunch Intensifies
The $2.0 million upfront payment and quarterly installments add immediate cash obligations to a company already flagged with going-concern doubt and a cash crisis in its August 14, 2026 10-Q.
Analysis · GCTK · Industrial Applications And Services
A disputed $10.9 million indebtedness claim has been resolved, with Glucotrack agreeing to pay $2.0 million upfront, issue a $2.0 million convertible note, and cover up to $125,000 in legal fees. The note converts at $2.98 per share — below the current $3.17 price — and carries a 9.99% ownership blocker. For a company with a market cap near $2.5 million and a going-concern warning from its last 10-Q, this settlement removes a major legal overhang but adds immediate cash obligations and potential dilution at a time when cash is already scarce.
How filings like this one have moved
In the 30 days to Oct 19, 2026, 37.9% of the 895 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.87%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GCTK was trading at $3.17 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.5M. The 52-week trading range was $2.90 to $212.10. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.